October 3, 2014 / 9:04 PM / in 3 years

Allergan CEO resigns from Edwards Lifesciences' board

Oct 3 (Reuters) - Edwards Lifesciences Corp said David Pyott resigned from the medical device maker’s board to devote more time to his role as chairman and CEO of Allergan Inc .

The resignation of Pyott, who joined Edwards’ board in 2000, is effective immediately, the company said in a statement.

Allergan is fighting a $53.7-billion hostile bid from Canada’s Valeant Pharmaceuticals International Inc and billionaire William Ackman’s Pershing Square.

Edwards Lifesciences shares closed at $106.18 Friday on the New York Stock Exchange. (Reporting by Shailesh Kuber in Bangalore; Editing by Anil D‘Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below